Assessment of immunogenicity involves evaluating the potential for biologics to induce an immune response. This is typically done through in vitro assays and animal models, followed by monitoring in clinical trials. Understanding immunogenicity is essential for predicting potential adverse effects and adjusting dosing regimens to minimize risks.
